Modified recombinant human erythropoietin with potentially reduced immunogenicity. Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R. Sci Rep. 2021 Jan 15;11(1):1491.

15 Jan 2021
0

Modified recombinant human erythropoietin with potentially reduced immunogenicity.

Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R.

Sci Rep. 2021 Jan 15;11(1):1491.

Tags

Share this

Related Posts

Proteomic analysis reveals plasma haptoglobin, interferon-γ, and interleukin-1β as potential biomarkers of pediatric refractory epilepsy. Saengow VE, Chiangjong W, Khongkhatithum C, Changtong C, Chokchaichamnankit D, Weeraphan C, Kaewboonruang P, Thampratankul L, Manuyakorn W, Hongeng S, Srisomsap C, Svasti J, Chutipongtanate S, Visudtibhan A. Brain Dev. 2021 Mar;43(3):431-439.

Recent Posts